CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (1,143,449)	$ 1,147,475
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	465,341	451,207
Accretion of asset retirement obligation	6,736	11,412
Common stock payable for directors fees	0	75,000
Write down of inventory to net realizable value	456,238	136,836
Change in fair value of investments	0	93,458
Changes in operating assets and liabilities:
Accounts receivable, net	(523,517)	(713,346)
Inventories	(1,431,475)	328,380
Prepaid expenses and other current assets	(240,225)	(60,916)
IVA receivable and other assets	(320,820)	(86,442)
Accounts payable	(221,673)	(706,155)
Accrued liabilities	11,856	64,045
Accrued liabilities - directors	139,208	4,084
Royalties payable	(389,716)	0
Net cash provided (used) by operating activities	(3,191,496)	745,038
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments	0	(13,789,772)
Proceeds from sales of investments	0	396,921
Purchase of properties, plants and equipment	(1,347,856)	(382,999)
Net cash used by investing activities	(1,347,856)	(13,775,850)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments of long-term debt	(46,369)	(19,767)
Dividends paid	(787,730)	0
Net cash used by financing activities	(834,099)	(19,767)
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(5,373,451)	(13,050,579)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD	19,117,666	21,420,329
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	$ 13,744,215	8,369,750
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Common stock retirement	202,980
Conversion of Preferred Series D to Common Stock	$ 16,927	0
Equipment purchased with note payable	$ 0	$ 161,600